3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields; and surfactant-like peptide, as well as High Concentration PuraMatrix, a high concentration hydrogel; and GMP Grade PuraMatrix. The company was incorporated in 2004 and is based in Tokyo, Japan.
Research context
3-D Matrix, Ltd appears in PyInvesting’s Tokyo Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
3-D Matrix, Ltd is currently in a long term uptrend where the price is trading 17.7% above its 200 day moving average.
From a valuation standpoint, the stock is 80.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 13.5.
3-D Matrix, Ltd's total revenue rose by 21.8% to $232M since the same quarter in the previous year.
Its net income has increased by 27.9% to $-478M since the same quarter in the previous year.
Based on the above factors, 3-D Matrix, Ltd gets an overall score of 4/5.